Carverter is a technology platform that enables customers to find and lease a hybrid or Electric Vehicle (EV). The company cites data pointing out the UK government's ban on the sale of petrol and diesel only cars after 2030. It also argues about changing car preferences, with 78% of consumers considering leasing to access an EV. Carverter aims to capture this audience and grow its business. The company uses its algorithm to bring together over 32 million data points across its three tools, namely Carvert, Carwizard, and Browse, to help users find their choice of hybrid/EV. Carverter has partnered with renowned entities like WPP, Arval, Microsoft & ITV to boost its business. It will use 10% of the investment on hiring staff, 20% towards rolling out its services across 22 European countries via Arval, and 70% on an advertising multiplier deal with the UK's largest commercial broadcaster, ITV, and WPP.
days to go:
Expired
investment:
£2,324,693
Movem is a platform where tenants, landlords and agencies have been sharing their rental experiences since 2013. Building a digital rental profile known as a Movem Passport. Landlords and agents can pay to instantly download a tenant's full reference, designed to be quicker, cheaper and less open to fraud.
days to go:
Expired
investment:
£395,580
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go:
Expired
investment:
£76,030
Solivus is a solar technology company that aims to enable mega-buildings, homes and communities to lower their carbon footprint and generate local green energy through the company's proprietary solar solutions. Its patent-pending innovation, Solivus Arc, utilises thin-film solar technology to power homes and electric vehicles. The company asserts that Solivus Arc provides an alternative to rooftop solar and has incredible low-carbon credentials. Solivus aims to also enter the commercial and agricultural markets with its products. It will use 50% of the investment in product development and R&D, 40% in growing its team, and 10% towards legal and marketing costs.
days to go:
Expired
investment:
£1,619,048
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
The go-to platform for people planning the most important purchase of their lives: a new home.
days to go:
Expired
investment:
£103,008
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go:
Expired
investment:
£2,005,050
Ecologi is dedicated to motivating and enabling businesses to expedite global climate action. Through Ecologi Zero, their carbon footprinting tool with Xero, customers can calculate emission and establish reduction objectives, while also funding tree planting and high quality carbon avoidance and removal projects.
They can share their impact dashboard encourage and inspiring others, and all of this is made possible through monthly Climate Action subscriptions, PAYG Impact shop, and Ecommerce API.
days to go:
Expired
investment:
£549,363
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.
days to go:
Expired
investment:
Withheld
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
days to go:
Expired
investment:
£737,480
